Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency

被引：87

作者：

Gaudet, Daniel ^{[1
]}

de Wal, Janneke ^{[2
]}

Tremblay, Karine ^{[1
]}

Dery, Stephane ^{[1
]}

van Deventer, Sander ^{[2
]}

Freidig, Andreas ^{[2
]}

Brisson, Diane ^{[1
]}

Methot, Julie ^{[1
]}

机构：

[1] Univ Montreal, Dept Med, ECOGENE Clin Res Ctr 21, Chicoutimi Hosp, Chicoutimi, PQ G7H 7P2, Canada

[2] Amsterdam Mol Therapeut AMT BV, Amsterdam, Netherlands

来源：

ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 01期

基金：

加拿大健康研究院;

关键词：

Lipoprotein lipase; Gene therapy; Pancreatitis; Chylomicronaemia; RENAL-TRANSPLANT RECIPIENTS; CHRONIC-PANCREATITIS; MYCOPHENOLATE-MOFETIL; RANDOMIZED-TRIAL; CYCLOSPORINE; MUTATIONS; RISK; MULTICENTER; COMBINATION;

D O I：

10.1016/j.atherosclerosissup.2010.03.004

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Alipogene tiparvovec (AAV1-LPLS447X) gene therapy is developed to prevent complications and decrease the clinical morbidity of lipoprotein lipase deficiency (LPLD). LPLD is an autosomal recessive disease associated with severe hypertriglyceridemia (hyperTG), severe chylomicronaemia, and low HDL. Acute pancreatitis, the most frequent serious clinical LPLD complication, is a complex and heterogeneous inflammatory condition having many causes including hyperTG and chylomicronaemia. In many patients, low fat diet and currently available lipid lowering drugs are ineffective to prevent hyperTG or pancreatitis in LPLD. The clinical development program of alipogene tiparvovec includes observational studies as well as phase I/II and II/III clinical trials. Pooled data are collected on safety and efficacy issues, including the incidence of pancreatitis. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

引用

页码：55 / 60

页数：6

共 33 条

[21] Recent developments in gene transfer: risk and ethics
Kimmelman, J
[J]. BRITISH MEDICAL JOURNAL, 2005, 330 (7482): : 79 - 82
[22] AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells
Mingozzi, Federico
Meulenberg, Janneke J.
Hui, Daniel J.
Basner-Tschakarjan, Etiena
Hasbrouck, Nicole C.
Edmonson, Shyrie A.
Hutnick, Natalie A.
Betts, Michael R.
Kastelein, John J.
Stroes, Erik S.
High, Katherine A.
[J]. BLOOD, 2009, 114 (10) : 2077 - 2086
[23] PARADIS G, 2001, THESIS U LAVAL QUEBE
[24] Combination of circulating antilipoprotein lipase (anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia
Pruneta-Deloche, V
Marçais, C
Perrot, L
Sassolas, AS
Delay, M
Estour, B
Lagarde, M
Moulin, P
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07) : 3995 - 3998
[25] Gene therapy for lipoprotein lipase deficiency: Working toward clinical application
Rip, J
Nierman, MC
Sierts, JA
Petersen, W
Van Den Oever, K
Van Raalte, D
Ross, CJD
Hayden, MR
Bakker, AC
Dijkhuizen, P
Hermens, WT
Twisk, J
Stroes, E
Kastelein, JJP
Kuivenhoven, JA
Meulenberg, JM
[J]. HUMAN GENE THERAPY, 2005, 16 (11) : 1276 - 1286
[26] AAV1-LPL S447X gene therapy reduces hypertriglyceridemia in apoE2 knock in mice
Rip, Jaap
van Dijk, Ko Willems
Sierts, Jeroen A.
Kastelein, John J. P.
Twisk, Jaap
Kuivenhoven, Jan Albert
[J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2006, 1761 (10): : 1163 - 1168
[27] Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients - A prospective, multicenter, randomized study
Sadek, S
Medina, J
Arias, M
Sennesael, J
Squifflet, JP
Vogt, B
[J]. TRANSPLANTATION, 2002, 74 (04) : 511 - 517
[28] The familial chylomicronemia syndrome
Santamarina-Fojo, S
[J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1998, 27 (03) : 551 - +
[29] Clinical characterization of patients with idiopathic chronic pancreatitis and SPINK1 mutations
Schneider, A
Barmada, MM
Slivka, A
Martin, JA
Whitcomb, DC
[J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (09) : 903 - 904
[30] Intramuscular Administration of AAV1-Lipoprotein LipaseS447X Lowers Triglycerides in Lipoprotein Lipase-Deficient Patients
Stroes, Erik S.
Nierman, Melchior C.
Meulenberg, Janneke J.
Franssen, Remco
Twisk, Jaap
Henny, C. Pieter
Maas, Mario M.
Zwinderman, Aeilko H.
Ross, Colin
Aronica, Eleonora
High, Katherine A.
Levi, Marcel M.
Hayden, Michael R.
Kastelein, John J.
Kuivenhoven, Jan Albert
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (12) : 2303 - U264

← 1 2 3 4 →